July 1, 2024 02:40 JST TOKYO -- Japanese pharmaceutical company Eisai is developing an Alzheimer's disease treatment that targets a protein linked to symptoms, aiming to release it in the U.S. by fiscal 2030, Nikkei has learned.
Small-scale clinical trials are underway to confirm the safety of the drug candidate, which targets tau proteins. Such drugs, though difficult to develop, are expected to be highly effective if successful.
We discovered this fact during 1980s, now then amyloid drug developers realise targeting Tau can produce much more powerful results. We are lightyears ahead of any real clinically credible AD drug.
It would be impossible for UK authorities to approve and authorize Taurx this year. Anyone in this forum can forcast, hypothesize and predict approval from UK this year. 100% IMPOSSIBLE for UK approval in 2024. Of course, anyone can say anything in forum. @ATK is correct.
Posted by neohts > 1 hour ago | Report Abuse that Thestar.com news is for ELI Lilly. ----------
I know. I replied with links abt the truth of Donanemab. Pay abt US$50k/yr actual treatment for a useless intravenous drug with numerous PET / MRI scans and consultations + iffy trial results (see how they calculate final trial result by excluding those serious side effects/death patients who dropped out trial) + brain bleeding + accelerated brain shrinkage. Generic Aricept drug can produce even better results at 2% of actual treatment cost. Thats a real solid advancement not for Science but purely for doctors' and drug developer's profit! 👏👏👏
genting in news..... unfortunately not the company but just the location and land deal :-) but for such a small piece the development value goes into $$$billion.... shd consider selling land as business
2JUL Foreign fund nett buying 37M, 3JUL+259M. However foreign fund didn't buy Genting yesterday, they buy contructions, utilities, technology, O&G...... When is Genting turn?
For those who bought ytl in 2018. They were wasting their time too at that moment. So what... They succeed to get 5 fold in return if they hold until now. Thats normal
Yes... Ah Pek scares kena heart attack.. Then Ah Pek just buy in low... What you call theme play stocks is what Ah Pek did hold before. Ytl Ytlp. and thankful A Pek made quite handsome profit out of them
When Ah Pek started buying Ytl Ytlp, someone also shouting of buying theme play stocks, if not mistaken are those glove and tech stocks...after that, they were all masuk longkang. Theme play stocks.... What the hell is that?? 🤭
In Malaysia, however..data centres are the talk of the town and a popular investment theme. What's happening arr? If you have made money in data centre stocks, be content and bear in mind that not all data centres are suitable for long-term investment..
This paper should have elaborated more on accelerated brain shrinkage aspect of Mab class of drugs. Brain neurons dying at faster rate, meaning these treatments are definitely going in the wrong direction. Its a known fact that AD brains shrink faster than normal brains as this rate of brain shrinkage is the purest form of physical biomarker whether the drug is working well or not. These drugs are just giving weak symptomatic effect for 12 months, something Aricept can do much better 25 years ago. Beyond 12 months, the downward slopes shown on graphs are both parallel sloping, indicating these are just symptomatic drugs and not disease modifying as claimed. There has to be some serious brain damage done to those patients here, the real effects can only be seen after a few years of using these drugs.
This Genting become rubbish stock until further notice , August QR gurantee decrease net profit will drag price to 4.30 , waste time talk rubbish , May QR excelent cause Feb Chinese new year n 1 month curi sekolah ,causing a lot visitor visit Genting , now everything. Back normal , Maintain SELL , TP = 4.30
Johnchew still bullish on Genting... 4.30 you are so kind... I am waiting you to dump more, my dear.... Aiya 3.99 prepare to load... Johnchew start your selling process pls🤭
What??? Talk only??? I rather can talk until the moon drop🤭 Waste my time. One way you RSS Rm 1mil genting share to me @ Rm4 then you reload later whatsoever you like. Can or not. Or else dont talk rubbish lah🤭🤭🤭
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
AngTayKor
2,352 posts
Posted by AngTayKor > 2 months ago | Report Abuse
https://x.com/AlbertoEspay/status/1800638243056058709
https://x.com/AlbertoEspay/status/1806646390031802876
https://x.com/DanClintonRN/status/1801414681883500698?t=quIksYT-SopFLU0Lhc25Nw&s=08